CEO iDNA Ltd, London
Dr. Rizzo got his Biology degree at the “La Sapienza” University of Rome, his PhD in Oncology and his specialization in microbiology at the University of Perugia, Italy, his post-graduate qualification in preclinical development of drugs from University “La Bicocca” Milano and his Master in Business Administration (MBA) at the HULT International Business School, London. He is member of board of directors and Chief of Innovation Division of Zcube, Zambon group. Dr Rizzo has as extensive experience in drug discovery and development and in medical device development: head of biology of Intercept Pharmaceuticalss Inc.; Consultant of Index Ventures, a venture capital firm. CEO of iDNA Ltd, a drug discovery service company; Vice President of Yaqrit Ltd, a spin off company of the University College London. He is an entepreneur and an investor himself of the London Business Angels (LBA); MedCity Angels, London; and Italian Angels for Biotech, Italy. He has a honorary senior lecturer position at the University College London (UCL) in the Institute of Liver and Digestive Health (ILDH).